Testing Two Different Doses of Tiotropium Respimat(R) in Cystic Fibrosis: Phase 2 Randomized Trial Results.
primary studies published RCT
Details- 2014
- Bradley JM
Disrupted intestinal microbiota and intestinal inflammation in children with cystic fibrosis and its restoration with Lactobacillus GG: a randomised clinical trial.
primary studies published RCT
Details- 2014
- Bruzzese E
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis
primary studies published RCT
Details- 2014
- Calabrese C
Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled trial.
primary studies published RCT
Details- 2014
- Conrad C
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation
primary studies published RCT
Details- 2014
- De Boeck K
Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study.
primary studies published RCT
Details- 2014
- del Campo R
Efficacy and tolerability of a new nasal spray formulation containing hyaluronate and tobramycin in cystic fibrosis patients with bacterial rhinosinusitis.
primary studies published RCT
Details- 2014
- Di Cicco M
Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis.
primary studies published RCT
Details- 2014
- DiMango E
Improving the quality of physician communication with rapid-throughput analysis and report cards.
primary studies published RCT
Details- 2014
- Farrell MH
Tobramycin inhalation powder in cystic fibrosis patients: Response by age group.
primary studies published RCT
Details- 2014
- Geller DE